Table 6.
Group | SOD (U/mL) |
NO (μmol/L) |
CAT (U/mL) |
MDA (μmol/L) |
GSH-Px (U/mL) |
---|---|---|---|---|---|
Normal | 140.38 ± 8.33a | 47.26 ± 4.33d | 42.68 ± 2.83a | 5.43 ± 0.32d | 266.38 ± 7.81a |
Model | 42.11 ± 4.99d | 137.61 ± 5.86a | 9.10 ± 1.26d | 22.65 ± 1.34a | 82.25 ± 4.70d |
Silymarin | 97.39 ± 5.33b | 83.98 ± 3.28c | 30.00 ± 1.17b | 7.99 ± 0.14c | 205.38 ± 12.45b |
SPL | 70.76 ± 6.01c | 119.68 ± 6.10b | 15.24 ± 0.97c | 15.32 ± 0.76b | 139.92 ± 8.11c |
SPH | 94.91 ± 3.01b | 87.95 ± 4.39c | 29.27 ± 1.10b | 8.25 ± 0.18c | 193.25 ± 12.21b |
Values presented are the mean ± standard deviation (N = 10/group). Sample data in each group come from normal distribution, and the difference in variance between the two groups was significant (P > 0.05). a-dMean values with different letters over the bar are significantly different (P < 0.05) according to Tukey's honestly significant difference. Normal: untreated mice; model: CCl4-treated mice; SPL: 100 mg/kg Shoumei polyphenols and CCl4-treated mice; SPH: 200 mg/kg Shoumei polyphenols and CCl4-treated mice; silymarin: 200 mg/kg silymarin and CCl4-treated mice. SOD: superoxide dismutase; NO: nitric oxide; CAT: catalase; MDA: malondialdehyde; GSH-Px: glutathione peroxidase.